Background & Aims: Barrett's esophagus is associated with adenocarcino
ma of the esophagus. The aim of this study was to find the prevalence
of Barrett's esophagus in patients with adenocarcinoma of the esophago
gastric junction. Methods: Consecutive, freshly resected surgical esop
hagogastrectomy specimens were examined, and multiple histological sec
tions were made around the tumor periphery. Barrett's esophagus was de
fined as specialized columnar epithelium above the esophagogastric jun
ction. Tumors centered less than or equal to 2 cm from the junction we
re defined as junction cancers. Results: Barrett's esophagus was found
in 9 of 9 (100%) esophageal adenocarcinomas compared with 0 of 8 (0%)
squamous carcinoma controls (P < 0.001). Ten of 24 (42%) junction ade
nocarcinomas had a Barrett's esophagus. A Barrett's esophagus was foun
d in 8 of 12 (67%) junction cancers less than or equal to 6 cm in leng
th but only 2 of 12 (17%) larger tumors (P < 0.05). Barrett's esophagu
s was significantly associated with junction tumors; <6 cm compared wi
th squamous carcinoma controls (P < 0.02). In 5 specimens with junctio
n cancer, the length of Barrett's esophagus was <3 cm, and in 5 specim
ens it was greater than or equal to 3 cm. Specialized epithelium was o
ften found below the esophagogastric junction in controls. Conclusions
: Adenocarcinomas of the esophagogastric junction are associated with
short and long segments of Barrett's esophagus. Larger cancers probabl
y overgrow and conceal the underlying specialized columnar epithelium
from which they arise.